Your browser doesn't support javascript.
Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.
Alishaq, Moza; Nafady-Hego, Hanaa; Jeremijenko, Andrew; Al Ajmi, Jameela Ali; Elgendy, Mohamed; Vinoy, Suni; Fareh, Sameera Bihi; Veronica Plaatjies, Justine; Nooh, Mariam; Alanzi, Nadya; Kaleeckal, Anvar H; Latif, Ali Nizar; Coyle, Peter; Elgendy, Hamed; Abou-Samra, Abdul-Badi; Butt, Adeel Ajwad.
  • Alishaq M; Hamad Medical Corporation, Doha, Qatar.
  • Nafady-Hego H; Microbiology and Immunology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Jeremijenko A; Hamad Medical Corporation, Doha, Qatar.
  • Al Ajmi JA; Hamad Medical Corporation, Doha, Qatar.
  • Elgendy M; Faculty of Medicine, Universiti Sains of Malaysia, Kelantan, Malaysia.
  • Vinoy S; Hamad Medical Corporation, Doha, Qatar.
  • Fareh SB; Hamad Medical Corporation, Doha, Qatar.
  • Veronica Plaatjies J; Hamad Medical Corporation, Doha, Qatar.
  • Nooh M; Hamad Medical Corporation, Doha, Qatar.
  • Alanzi N; Hamad Medical Corporation, Doha, Qatar.
  • Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar.
  • Latif AN; Hamad Medical Corporation, Doha, Qatar.
  • Coyle P; Hamad Medical Corporation, Doha, Qatar.
  • Elgendy H; Hamad Medical Corporation, Doha, Qatar.
  • Abou-Samra AB; Weill Cornell Medical College, New York, NY, United States of America and Doha, Qatar.
  • Butt AA; Anesthesia Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
PLoS One ; 16(10): e0258820, 2021.
Article in English | MEDLINE | ID: covidwho-1470667
ABSTRACT
BACKGROUND AND

OBJECTIVE:

The risk factors for breakthrough infections among healthcare workers (HCW) after completion of a full course of vaccination are poorly understood. Our objective was to determine the risk factors for breakthrough SARS-CoV-2 infection among HCWs at a national healthcare system in Qatar.

METHODS:

We identified all HCWs at Hamad Medical Corporation in Qatar between December 20, 2020 and May 18, 2021 with confirmed SARS-CoV-2 RT-PCR infection >14 days after the second vaccine dose. For each case thus identified, we identified one control with a negative test after December 20, 2020, matched on age, sex, nationality, job family and date of SARS-CoV-2 testing. We excluded those with a prior positive test and temporary workers. We used Cox regression analysis to determine factors associated with breakthrough infection.

RESULTS:

Among 22,247 fully vaccinated HCW, we identified 164 HCW who had breakthrough infection and matched them to 164 controls to determine the factors associated with SARS-CoV-2 breakthrough infection. In the breakthrough infection group the nursing and midwifery job family constituted the largest group, spouse was identified as the most common positive contact followed by a patient. Exposure to a confirmed case, presence of symptoms and all other job families except Allied Health Professionals when compared with nursing and Midwifery staff independently predicted infection.

CONCLUSION:

Presence of symptoms and contact with a confirmed case are major risk factors for breakthrough SARS-CoV-2 infection after vaccination, and these groups should be prioritized for screening even after full vaccination.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / Health Personnel / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0258820

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / Health Personnel / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0258820